NCT04296955

Brief Summary

A randomized controlled study (RCT) aiming to test the effect of a new health literacy intervention for renal transplant recipients, KnowMAP (knowledge management for renal transplant recipients).

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 3, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

March 9, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2021

Completed
4.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

March 19, 2025

Status Verified

March 1, 2025

Enrollment Period

1.3 years

First QC Date

March 3, 2020

Last Update Submit

March 18, 2025

Conditions

Keywords

health literacymotivational interviewadherenceorgan transplantation

Outcome Measures

Primary Outcomes (2)

  • Health literacy (HL)

    HL measured by the HLQ (Health Literacy Questionnaire): The HLQ includes 44 items over nine independent scales, each representing a different element of the overall HL construct. Each scale includes 4-6 items. The first five scales comprise items asking the respondents to indicate level of agreement \[ranging from strongly disagree to strongly agree (range 1-4)\]. The remaining scales (6-9) have domains of self-reported capability (range 1-5: 'cannot do' to 'very easy'). The questionnaire has no total score, as that could potentially mask individual needs in specific HL domains. The HLQ appears robust for its intended purpose of assessing HL in a range of settings and has shown excellent reliability.

    24 months post transplantation

  • Adherence to immunosuppressive medication

    The instrument BAASIS (The BAsel Adherence to immunoSuppressIve medication Scale) a self reporting adherence questionnaire measuring patients' taking, skipping, timing (\>2 hrs from prescribed time) and dose reduction of drugs. The recall period is limited to four weeks. The BAASIS comprises four questions with a 6-point scale for responses ranging from never (0) to every day (5)

    24 months post transplantation

Secondary Outcomes (3)

  • Quality of life and cost-effectiveness estimates relevant to this clinical context

    24 months post transplantation

  • Knowledge

    24 months post transplantation

  • Occations of graft loss

    24 months post transplantation

Study Arms (2)

Health communication intervention

EXPERIMENTAL

Motivational interview as a new health communication intervention (one arm)

Other: Motivational interview as a new health communication intervention

Standard care

NO INTERVENTION

Standard care

Interventions

Same as intervention name

Health communication intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Kidney transplanted patients \> 18 years included within few days after kidney transplantation at Oslo University Hospital
  • Able to speak and understand Norwegian

You may not qualify if:

  • Not able to speak or understand Norwegian well enough to be able to fill out forms or have a conversation in Norwegian.
  • Kidney transplanted patient \<18 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0424, Norway

Location

MeSH Terms

Interventions

Motivational Interviewing

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Andersen

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Block randomization
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Interventional study model: Parallel assignment. 2- arm un-blinded RCT design. The arms are: 1. The intervention: 4 individual patient counseling sessions using adapted motivational interviewing techniques in addition to usual care. 2. Usual care: patients undergo standard patient education program for renal transplant recipients at OUS.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD student

Study Record Dates

First Submitted

March 3, 2020

First Posted

March 5, 2020

Study Start

March 9, 2020

Primary Completion

June 15, 2021

Study Completion

October 31, 2025

Last Updated

March 19, 2025

Record last verified: 2025-03

Locations